Tài liệu tham khảo |
Loại |
Chi tiết |
1. D.J.W Grant, Theory and origin of polymorphism, in : H.G. Brittain (Ed.), Polymorphism in Pharmaceutical Solids, Vol.95, Marcel Dekeker, New York, pp. 1 – 33, 1999 |
Sách, tạp chí |
Tiêu đề: |
Polymorphism in Pharmaceutical Solids |
|
2. Geoff G.Z. Zhanga, Devalina Lawa, Eric A. Schmittb, Yihong Qiu, Phase transformation considerations during process development and manufacture of solid oral dosage forms, Advanced Drug Delivery Reviews, Vol. 56, pp. 371– 390, 2004 |
Sách, tạp chí |
Tiêu đề: |
Phase transformation considerations during process development and manufacture of solid oral dosage forms |
|
3. Andre S. Raw*, M. Scott Furness, Devinder S. Gill, Richard C. Adams, Frank O. Holcombe Jr., Lawrence X. Yu, Regulatory considerations of pharmaceutical solid polymorphism in Abbreviated New Drug Applications (ANDAs), Advanced Drug Delivery Reviews, Vol.56, pp. 397– 414, 2004 |
Sách, tạp chí |
Tiêu đề: |
Regulatory considerations of pharmaceutical solid polymorphism in Abbreviated New Drug Applications (ANDAs) |
|
4. SudhaR., Vippagunata, Harry G. Brittain, David J.W. Grant, Crystalline solids, Advanced Drug Delivery Reviews, Vol.48, pp. 3 – 26, 2001 |
Sách, tạp chí |
Tiêu đề: |
Crystalline solids |
|
5. S.L. Morissette, Orn Almarsson, Matthew L. Peterson, J.F. Remenar, M. J. Read, A.V. Lemmo, S. Ellis, M. J. Cima, C. R. Gardner, High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids, Advanced Drug Delivery Review, Vol.56, pp. 275 – 300, 2004 |
Sách, tạp chí |
Tiêu đề: |
High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids |
|
6. F.D. Cazer, G.E. Parry, D.M. Billings, N.L. Redman-Furey, Selective crystallization of 3- pyridiyl-1-hydroxyethylene-1,1-bisphosphonic acid sodium as the hemi-pentahydrate or monohydrate, US Patent US006410520B2, 25 Jun, 2002 |
Sách, tạp chí |
Tiêu đề: |
Selective crystallization of 3-pyridiyl-1-hydroxyethylene-1,1-bisphosphonic acid sodium as the hemi-pentahydrate or monohydrate |
|
7. J.E. Godlewski, Process for controlling crystal structure of Risedronate, US Patent US007002014 B2, 21 Feb, 2006 |
Sách, tạp chí |
Tiêu đề: |
Process for controlling crystal structure of Risedronate |
|
8. J. Richter, J. Jirman, H. Petrichova, Amorphous forms of Risedronate monosodium, US 2007/0142332 A1, 21 Jun, 2007 |
Sách, tạp chí |
Tiêu đề: |
Amorphous forms of Risedronate monosodium |
|
9. J. Aronhime, E. Lifshitz-Liron, E. Kovalevski-Ishai, Novel polymorphs and pseudopolymorphs of Risedronate Sodium, PCT WO 03/0086355 A1, 23 Oct, 2003 |
Sách, tạp chí |
Tiêu đề: |
Novel polymorphs and pseudopolymorphs of Risedronate Sodium |
|
10. J. Richter, J. Jirman, A new crystalline form of the sodium salt of 3-pyridiyl-1- hydroxyethylene-1,1-bisphosphonic acid, PCT WO 2004/037252 A1, 6 May, 2004 |
Sách, tạp chí |
Tiêu đề: |
A new crystalline form of the sodium salt of 3-pyridiyl-1-hydroxyethylene-1,1-bisphosphonic acid |
|
11. Nancy Redman-Furey, , M. Dicks, A. Bigalow-Kern, R. T. Cambron, G. Lubey, C. Lester, D. Vaughn, Structural and analytical characterization of three hydrates and an anhydrate form of Risedronate, Journal of Pharmaceutical Sciences, Vol.94, No.4, April 2005 |
Sách, tạp chí |
Tiêu đề: |
Structural and analytical characterization of three hydrates and an anhydrate form of Risedronate |
|
14. Colin R. Gardner, C. T. ệrn Almarsson, Drugs as materials: Valuing Physical form in drug discovery, Drug Discovery – Nature Reviews, Vol.3, pp. 926 – 934, November 2004 15. S. L. Morissette, Elucidation of Crystal Form Diversity of the HIV Protease InhibitorRitonavir by High-throughput Crystallization, Proceedings of National Academy of Science |
Sách, tạp chí |
Tiêu đề: |
Drugs as materials: Valuing Physical form in drug discovery", Drug Discovery – Nature Reviews, Vol.3, pp. 926 – 934, November 2004 15. S. L. Morissette, "Elucidation of Crystal Form Diversity of the HIV Protease Inhibitor "Ritonavir by High-throughput Crystallization |
|
16. Guidance for Industry, ANDAs: Pharmaceutical solid polymorphism, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, December 2004 |
Sách, tạp chí |
Tiêu đề: |
ANDAs: Pharmaceutical solid polymorphism, U.S. Department of Health and Human Services |
|
17. Naír Rodríguez-Hornedo, S. J. Nehm, Adivaraha Jayasankar, Cocrystals: Design, properties and formation mechanisms, Encyclopedia of Pharmaceutical Technology, pp. 615 – 635, 2007 |
Sách, tạp chí |
Tiêu đề: |
Cocrystals: Design, properties and formation mechanisms |
|
18. G. Chawla & A K Bansal, Challenges in Polymorphism of Pharmaceuticals, CRIPS, Vol.5, No.1, January-March, 2004 |
Sách, tạp chí |
Tiêu đề: |
Challenges in Polymorphism of Pharmaceuticals |
|
19. G. Chawla, S. Banga and A.K. Bansal, High-throughput polymorph screening of pharmaceuticals–‘Farming for crystal mutants’, Business Briefing: Future Drug Discovery, pp. 66–72, 2004 |
Sách, tạp chí |
Tiêu đề: |
High-throughput polymorph screening of pharmaceuticals–‘Farming for crystal mutants |
|
21. Jay R. Smith † , Weizong Xu ‡ , and Daniel Raftery*, Analysis of Conformational Polymorphism in Pharmaceutical Solids Using Solid-State NMR, and Electronic Structure Calculations, J. Phys. Chem. B, Vol.110, pp. 7766 – 7776, 2006 |
Sách, tạp chí |
Tiêu đề: |
Analysis of Conformational Polymorphism in Pharmaceutical Solids Using Solid-State NMR, and Electronic Structure Calculations |
|
23. Elizabeth Balchin + , David J. Malcolme-Lawes + , Iain J. F. Poplett + , Michael D. Rowe + , John A. S. Smith * , Gareth E. S. Pearce ‡ and Stephen A. C. Wren, Potential of Nuclear Quadrupole Resonance in Pharmaceutical Analysis, Anal. Chem., Vol. 77, pp. 3925 – 3930, 2005 |
Sách, tạp chí |
Tiêu đề: |
Potential of Nuclear Quadrupole Resonance in Pharmaceutical Analys |
|
24. Rama A. Shmeis * , Steven L. Krill, Weak solid–solid transitions in pharmaceutical crystalline solids detected via thermally stimulated current, Thermochimica Acta, Vol. 427, pp. 61–68, 2005 |
Sách, tạp chí |
Tiêu đề: |
Weak solid–solid transitions in pharmaceutical crystalline solids detected via thermally stimulated current |
|
25. Sarah L. Price*, The computational prediction of pharmaceutical crystal structures and polymorphism, Advanced Drug Delivery Reviews, Vol. 56, pp. 301– 319, 2004 |
Sách, tạp chí |
Tiêu đề: |
The computational prediction of pharmaceutical crystal structures and polymorphism |
|